In 1994, the Malmo-Klaipeda twinning programme was approved by the Wor
ld Federation of Hemophilia. One of the first steps in the collaborati
on has been to set up a registry of the haemophilia patients in the Kl
aipeda area. In order to collect important clinical data the patients
have been examined jointly by experts on haemophilia from the two cent
res. Seventeen out of 25 patients with severe haemophilia known at the
Klaipeda centre were examined and compared to a matched cohort of pat
ients from the Malmo centre. The main differences between the cohorts
were that home treatment was not available to the Klaipeda patients, t
hey received less treatment in general, had higher joint scores and mo
re frequent bleeds. The pattern of transmission of blood-borne virus w
as very similar, with a high prevalence of hepatitis C antibodies. We
conclude that the twinning programme between Malmo and Klaipeda has re
sulted in several achievements, including training of staff and a nece
ssary inventory of the patients. This should not only form a suitable
platform for the future development of haemophilia care in Lithuania,
but could also serve as an example for liaisons between other haemophi
lia centres.